Anavex Life Sciences Corporation (AVXL)

04:41 AM

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Yahoo

04:41 AM

07:40 AM

Anavex Life Sciences Presents Novel Alzheimer Treatment Research at International Conference in Abu Dhabi - Nasdaq

07:40 AM

07:30 AM

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East - TradingView

07:30 AM

Apr 20, 2025

Geode Capital Management LLC Has $20.14 Million Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 20, 2025

Apr 19, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Holdings Raised by Alliancebernstein L.P. - Defense World

Apr 19, 2025

Apr 13, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences LawsuitAVXL - ACCESS Newswire

Apr 13, 2025

Apr 13, 2025

Anavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The Moon - MSN

Apr 13, 2025

Apr 13, 2025

Wellington Management Group LLP Makes New $1.70 Million Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 13, 2025

Apr 12, 2025

Prudential Financial Inc. Acquires Shares of 10,160 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 12, 2025

Apr 12, 2025

Vanguard Group Inc. Sells 59,727 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 12, 2025

Apr 10, 2025

Corebridge Financial Inc. Trims Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 10, 2025

Apr 08, 2025

Biotech Company Finds High-Impact Alzheimer's Therapy in Europe - streetwisereports.com

Apr 08, 2025

Apr 08, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright - Defense World

Apr 08, 2025

Apr 08, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at D. Boral Capital - Defense World

Apr 08, 2025

Apr 07, 2025

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years - Benzinga

Apr 07, 2025

Apr 05, 2025

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease - The Manila Times

Apr 05, 2025

Apr 05, 2025

Breakthrough: New Alzheimer's Drug Cuts Cognitive Decline Over 4 Years in Clinical Trial - Stock Titan

Apr 05, 2025

Apr 05, 2025

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 05, 2025

Apr 02, 2025

Class Action Filed Against Anavex Life Sciences Corporation (AVXL)May 13, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

AVXL’s price-to-free cash flow ratio: What it means for investors - uspostnews.com

Apr 01, 2025

Apr 01, 2025

Commonwealth Equity Services LLC Buys 7,285 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Apr 01, 2025

Apr 01, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright - Defense World

Apr 01, 2025

Mar 31, 2025

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 31, 2025

Mar 31, 2025

Anavex Showcases Breakthrough CNS Therapies: CEO Details Pipeline at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 30, 2025

Heartland Advisors Inc. Takes Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat

Mar 30, 2025

Mar 28, 2025

19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Acquired by Proficio Capital Partners LLC - Defense World

Mar 28, 2025

Mar 28, 2025

Anavex Life Sciences (NASDAQ:AVXL) Trading Down 3.2%Here's Why - MarketBeat

Mar 28, 2025

Mar 27, 2025

AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

Mar 27, 2025

Mar 25, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by Intech Investment Management LLC - The AM Reporter

Mar 25, 2025

Mar 24, 2025

Charles Schwab Investment Management Inc. Purchases 11,239 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 24, 2025

Mar 22, 2025

Bank of New York Mellon Corp Has $2.37 Million Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 22, 2025

Mar 19, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL - Business Wire

Mar 19, 2025

Mar 19, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Atria Investments Inc - Defense World

Mar 19, 2025

Mar 17, 2025

Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus - TradingView

Mar 17, 2025

Mar 13, 2025

Proficio Capital Partners LLC Purchases New Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 13, 2025

Mar 09, 2025

Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXL - ACCESS Newswire

Mar 09, 2025

Mar 07, 2025

Anavex Life Sciences Corp. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 06, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Stake Raised by Rhumbline Advisers - Defense World

Mar 06, 2025

Mar 06, 2025

Private Advisor Group LLC Sells 17,488 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 06, 2025

Mar 05, 2025

IMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Mar 05, 2025

Mar 05, 2025

Y Intercept Hong Kong Ltd Makes New $243,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Mar 05, 2025

Mar 03, 2025

Anavex Life Sciences Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire

Mar 03, 2025

Mar 03, 2025

Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 – AVXL - ACCESS Newswire

Mar 03, 2025

Mar 03, 2025

Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineAVXL - ACCESS Newswire

Mar 03, 2025

Mar 01, 2025

27,052 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Atria Wealth Solutions Inc. - Defense World

Mar 01, 2025

Feb 28, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire

Feb 28, 2025

Feb 28, 2025

AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 28, 2025

Feb 28, 2025

D.A. Davidson & CO. Buys Shares of 11,385 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Feb 28, 2025

Feb 28, 2025

Contrasting Cortexyme (NASDAQ:CRTX) and Anavex Life Sciences (NASDAQ:AVXL) - Defense World

Feb 28, 2025

Feb 27, 2025

Anavex Life Sciences Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future - Yahoo Finance

Feb 27, 2025

Feb 27, 2025

Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024AVXL - ACCESS Newswire

Feb 27, 2025

Feb 26, 2025

When Will Anavex Life Sciences Corp. (NASDAQ:AVXL) Breakeven? - Simply Wall St

Feb 26, 2025